Coeptis Therapeutics
Quarterly Financials
| Values in thousands | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 |
|---|---|---|---|---|
Revenue | $1,863 | $0 | $1,501 | $0 |
Gross Profit | 931 | -431 | -250 | -250 |
EBITDA | -4,504 | -1,499 | -2,719 | -2,672 |
EBIT | -3,725 | -1,777 | -2,969 | -2,922 |
Net Income | -1,947 | -1,828 | -3,035 | -3,001 |
Net Change In Cash | 1,863 | 0 | 1,501 | 0 |
Free Cash Flow | -1,436 | -1,892 | -1,417 | -1,902 |
Cash | 532 | 1,137 | 1,555 | 1,029 |
Basic Shares | 1,924 | 39,806 | 37,569 | 35,544 |
Annual Financials
| Values in thousands | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|
Revenue | $0 | $0 | $75 |
Gross Profit | -1,001 | -1,001 | -372 |
EBITDA | -36,354 | -32,960 | -12,814 |
EBIT | -37,355 | -33,962 | -13,262 |
Net Income | -40,967 | -40,967 | -14,422 |
Net Change In Cash | 0 | 0 | 75 |
Free Cash Flow | -3,875 | -3,875 | -6,239 |
Cash | 3,791 | 3,791 | 2,179 |
Basic Shares | 14,295 | 14,295 | 10,914 |
